A single β-lactam exposure rapidly drives stable multidrug resistance in RecA-deficient bacteria through an SOS-independent mechanism involving oxidative stress-induced mutagenesis and ...

As the globe faces a rise in antibiotic-resistant bacteria—making traditional ... now better known for its applications in medicine and biotechnology. CRISPR systems in general act as "molecular ...

New drugs that target 'zombie' tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated ...

New drugs that target 'zombie' tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of Surrey, published in ...

Storied Japanese pharma Shionogi is upping its arsenal in the fight against antibiotic resistance. | Storied Japanese pharma ...

Anaerobic bacteria were among the first life forms on Earth and existed at a time when there was no oxygen in the atmosphere.

Washington State University and Mayo Clinic researchers have created an experimental catheter hub that uses electric current ...

Buried in the DNA of the long extinct woolly mammoth is a compound that scientists hope will one day yield a lifesaving antibiotic. In experiments, mammuthusin, as the compound is called, has ...

Four years ago, an ambitious pharmaceutical industry venture to tackle antibiotic resistance launched to invest in small companies that can develop two to four novel antibiotics by 2030 — and ...

Spero entered 2025 with $52.9 million to hand. Along with milestone payments from GSK, the biotech expects this money to fund operations into the second quarter of 2026.

Key Takeaways Blujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial treatment option for drug-resistant urinary tract infections (UTIs).